Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not yet recruiting Phase 3 Interventional

A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity

ClinicalTrials.gov ID: NCT07919405

Public ClinicalTrials.gov record NCT07919405. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 11:02 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) in Participants With Hypertension and Obesity

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is testing whether CagriSema is safe and works well in adults with high blood pressure and excess body weight. Participants will receive CagriSema, semaglutide, cagrilintide, or placebo, and treatment will be assigned by chance. CagriSema and cagrilintide are investigational medicines, while semaglutide is already available by prescription.

Study identification

NCT ID
NCT07919405
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
1,408 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 11, 2026 (Estimated)
Primary completion
Jun 1, 2028 (Estimated)
Completion
Jul 13, 2028 (Estimated)
Last update posted
Nov 5, 2026

2026 – 2028

United States locations

U.S. sites
57
U.S. states
20
U.S. cities
50
Facility City State ZIP Site status
John Muir Physicians Network Concord California 94520 —
Aurora FDRC Inc. Costa Mesa California 92627 —
Providence Medical Foundation Fullerton California 92835 —
Catalina Research Institute, LLC Montclair California 91763 —
Desert Oasis Hlthcr Med Group Palm Springs California 92262 —
N America Res Inst - San Dimas San Dimas California 91773 —
Chase Medical Research LLC Waterbury Connecticut 06708 —
Clinical Res Of W Florida Inc Clearwater Florida 33765 —
Renstar Medical Research Ocala Florida 34470 —
Florida Institute for Clinical research Orlando Florida 32825 —
Javara Inc. / Privia Medical Group Georgia LLC Albany Georgia 31707 —
Hope Clin Res & Wellness Conyers Georgia 30094 —
Endocrine Research Solutions, Inc Roswell Georgia 30076 —
Javara Inc. / Privia Medical Group Georgia LLC Savannah Georgia 31406 —
Great Lakes Clinical Trials Chicago Illinois 60640 —
Koch Research Morton Illinois 61550 —
Endeavor Health Skokie Illinois 60077 —
Evanston Premier Hlthcr Res Skokie Illinois 60077 —
SIU Medicine Springfield Illinois 62702 —
Midwest Inst For Clin Res Indianapolis Indiana 46260 —
Iowa Diabetes Research West Des Moines Iowa 50266 —
Graves Gibert Clinic Bowling Green Kentucky 42101 —
Monroe Biomedical Research, LLC Louisville Kentucky 40213 —
Northern Pines Hlth Ctr, PC Buckley Michigan 49620 —
Aa Mrc Llc Flint Michigan 48504 —
StudyMetrix Research LLC City of Saint Peters Missouri 63303 —
Amicis Centers of Clinical Research St Louis Missouri 63128 —
Seacoast Kidney & Htn Specialists Portsmouth New Hampshire 03801 —
Southgate Medical Group, LLP West Seneca New York 14224 —
Great Lakes Medical Research Westfield New York 14787 —
Accellacare_NC Raleigh North Carolina 27609 —
Medication Management, LLC Raleigh North Carolina 27609 —
Piedmont Healthcare, Inc. Statesville North Carolina 28625 —
Diab & Endo Assoc of Stark Co Canton Ohio 44718 —
Family Practice Center of Wadsworth Inc. Wadsworth Ohio 44281-9236 —
Lynn Institute of Norman Norman Oklahoma 73072 —
Clinical Res Collaborative Cumberland Rhode Island 02864 —
Coastal Carolina Res Ctr North Charleston South Carolina 29405 —
Spartanburg Medical Research Spartanburg South Carolina 29303 —
Holston Medical Group Pc Bristol Tennessee 37620 —
Holston Medical Group Kingsport Tennessee 37660 —
Clinical Research Associates Nashville Tennessee 37203 —
Amarillo Med Spec LLP Amarillo Texas 79124 —
Texas Diabetes & Endocrinology Austin Texas 78731 —
Texas Diabetes & Endocrinology, P.A._Austin Austin Texas 78749 —
Juno Research, LLC Bellaire Texas 77401 —
Baylor Jack and Jane Hamilton Dallas Texas 75226 —
Velocity Clin Res, Dallas Dallas Texas 75230 —
North Texas Endocrine Center Dallas Texas 75231 —
Discovery MM Services Inc Houston Texas 77036 —
The Endocrine Center Houston Texas 77079 —
Radiance Clinical Research Lampasas Texas 76550 —
DCOL Ctr for Clin Res Longview Texas 75605 —
Clinical Advancement Center San Antonio Texas 78212 —
Northeast Clinical Research of San Antonio San Antonio Texas 78233 —
Consano Clinical Research, LLC Shavano Park Texas 78231 —
Rainier Clin Res Ctr Inc Renton Washington 98057 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 155 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07919405, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 5, 2026 · Synced Nov 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07919405 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →